Interv Akut Kardiol. 2006;5(1):33-36

MYOCARDIAL FRACTIONAL FLOW RESERVE - TIPS AND TRICKS FOR CLINICAL PRACTICE

Martin Mates1, Jan Kováč2
1 Kardiocentrum dospělých, oddělení invazivní kardiologie interní kliniky 2. LF UK a FN Motol, Praha
2 Kardiologická klinika Glenfieldské všeobecné nemocnice, Velká Británie

Authors present some comments relating to the methods of measurement and evaluation of results of myocardial Fraction Flow Reserve (FFRmyo).

Keywords: coronary reserve, coronary heart disease, myocardial fractional flow reserve

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mates M, Kováč J. MYOCARDIAL FRACTIONAL FLOW RESERVE - TIPS AND TRICKS FOR CLINICAL PRACTICE. Interv Akut Kardiol. 2006;5(1):33-36.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Barbato E, Bartunek J, Aarnoudse W, Vanderheyden M, Staelens F, Wijns W, et al. Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses [In Process Citation]. Eur Heart J 2004; 25: 2034-2209. Go to original source... Go to PubMed...
    2. Jeremias A, Whitbourn RJ, Filardo SD, Fitzgerald PJ, Cohen DJ, Tuzcu EM, et al. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements. Am Heart J 2000; 140: 651-57. Go to original source... Go to PubMed...
    3. De Bruyne B, Pijls NH, Barbato E, Bartunek J, Bech JW, Wijns W, et al. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans 66. Circulation 2003; 107: 1877-83. Go to original source... Go to PubMed...
    4. Casella G, Leibig M, et al. Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? Am Heart J 2004; 148: 590-55. Go to original source... Go to PubMed...
    5. Koo BK, Kim CH, Na SH, Youn TJ, Chae IH, Choi DJ, et al. Intracoronary continuous adenosine infusion 231. Circulation. 2005; 69(8): 908-912. Go to original source... Go to PubMed...
    6. Bartunek J, Marwick TH, Rodrigues AC, Vincent M, Van Schuerbeeck E, Sys SU, et al. Dobutamine-induced wall motion abnormalities: correlations with myocardial fractional flow reserve and quantitative coronary angiography. J Am Coll Cardiol. 1996; 27(6): 1429-1436. Go to original source... Go to PubMed...
    7. Pijls NH. Is it time to measure fractional flow reserve in all patients? J Am Coll Cardiol. 2003; 41(7): 1122-1124. Go to original source... Go to PubMed...
    8. De Bruyne B, Hersbach F, Pijls NH, Bartunek J, Bech JW, Heyndrickx GR, et al. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but, ,Normal" coronary angiography. Circulation 2001; 104: 2401-2406. Go to original source... Go to PubMed...
    9. Fearon WF, Luna J, Samady H, et al. Fractional flow reserve compared with intravascular ultrasound guidance for optimizing stent deployment. Circulation 2001; 104: 1917-1922. Go to original source... Go to PubMed...
    10. Pijls NH, Klauss V, Siebert U, Powers E, Takazawa K, Fearon WF, et al. Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry Circulation. 2002; 105(25): 2950-2954. Go to original source... Go to PubMed...
    11. Koo BK, Kang HJ, Youn TJ, Chae IH, Choi DJ, Kim HS et al. Physiologic assessment of jailed side branch lesions using fractional flow reserve J Am Coll Cardiol. 2005; 46(4): 633-637. Go to original source... Go to PubMed...
    12. Van Schaardenburgh P, Bech JW, De Bruyne B, Hoorntje J, Michels HR, Koolen JJ, et al. It is necessary to stent non-ischaemic stenoses? Five year follow-up of the DEFER study. European Heart Journal 2005; 26: Abstract suppl. 638.
    13. Mates M, Hrabos V, Hajek P, Rataj O, Vojacek J. Long-term follow-up after deferral of coronary intervention based on myocardial fractional flow reserve measurement 215. Coron Art Dis. 2005; 16(3): 169-174. Go to original source... Go to PubMed...
    14. Bech GJ, De Bruyne B, Bonnier HJ, Bartunek J, Wijns W, Peels K, et al. Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement. J Am Coll Cardiol. 1998; 31(4): 841-847. Go to original source... Go to PubMed...
    15. Arslan F, Kaya MG, Van der Heijden, Doevendans PA, Timurkaynak T, CA. Deferal of PTCA on basis of fractional flow reserve in patients at high risk for coronary artery disease Eur Heart J 2005; 26: Abstract suppl. 638.
    16. Guidelines for percutaneous coronary interventions. Eur Heart J 2005; 26: 804-847.
    17. Bech GJ, Droste H, Pijls NH, De Bruyne B, Bonnier JJ, Michels HR, et al. Value of fractional flow reserve in making decisions about bypass surgery for equivocal left main coronary artery disease. Heart 2001; 86: 547-552. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.